Idexx Laboratories CAG — Total Revenue increased by 5.6% to $1.05B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.6%, from $919.84M to $1.05B. Over 4 years (FY 2021 to FY 2025), CAG — Total Revenue shows an upward trend with a 8.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong demand for veterinary diagnostic products and successful market penetration, while a decrease may signal competitive pressure or reduced veterinary clinic activity.
This metric represents the total gross sales generated by the Companion Animal Group segment, which includes diagnostic...
Comparable to segment-specific revenue lines in other life sciences or medical device companies focused on animal health or diagnostics.
idxx_segment_cag_total_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $745.60M | $732.50M | $719.10M | $761.18M | $784.09M | $764.99M | $748.53M | $827.28M | $866.65M | $837.16M | $821.27M | $889.29M | $922.30M | $891.99M | $870.47M | $919.84M | $1.02B | $1.01B | $998.47M | $1.05B |
| QoQ Change | — | -1.8% | -1.8% | +5.9% | +3.0% | -2.4% | -2.2% | +10.5% | +4.8% | -3.4% | -1.9% | +8.3% | +3.7% | -3.3% | -2.4% | +5.7% | +11.2% | -1.0% | -1.4% | +5.6% |
| YoY Change | — | — | — | — | +5.2% | +4.4% | +4.1% | +8.7% | +10.5% | +9.4% | +9.7% | +7.5% | +6.4% | +6.5% | +6.0% | +3.4% | +10.9% | +13.5% | +14.7% | +14.6% |